HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shahin Rafii Selected Research

Glioblastoma (Glioblastoma Multiforme)

1/2015Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling.
3/2011A target for antiangiogenic therapy: vascular endothelium derived from glioblastoma.
5/2009Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.
1/2007Tracking normalization of brain tumor vasculature by magnetic imaging and proangiogenic biomarkers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shahin Rafii Research Topics

Disease

40Neoplasms (Cancer)
11/2021 - 12/2002
7Neoplasm Metastasis (Metastasis)
11/2019 - 12/2002
6Leukemia
01/2020 - 03/2002
4Breast Neoplasms (Breast Cancer)
02/2016 - 10/2006
4Carcinogenesis
01/2015 - 11/2003
4Glioblastoma (Glioblastoma Multiforme)
01/2015 - 01/2007
3Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 12/2014
3Fibrosis (Cirrhosis)
10/2017 - 02/2016
3Liver Cirrhosis (Hepatic Cirrhosis)
10/2017 - 12/2016
3Vascular Remodeling
12/2016 - 03/2003
3Ischemia
10/2013 - 03/2005
3Hypoxia (Hypoxemia)
11/2010 - 05/2006
3Infections
05/2005 - 04/2002
3Cardiovascular Diseases (Cardiovascular Disease)
03/2004 - 05/2002
2COVID-19
01/2022 - 11/2020
2Vascular Diseases (Vascular Disease)
01/2020 - 10/2003
2Inflammation (Inflammations)
11/2019 - 06/2008
2Glioma (Gliomas)
05/2017 - 05/2009
2Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2016 - 11/2008
2Wounds and Injuries (Trauma)
05/2011 - 01/2010
2Spinocerebellar Ataxias (Spinocerebellar Ataxia)
03/2010 - 09/2009
2Cicatrix (Scar)
01/2010 - 03/2004
2Hyperplasia
06/2009 - 10/2006
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2008 - 01/2004
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1Vascular System Injuries
01/2022
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Emphysema
01/2021
1Microvascular Rarefaction
01/2021
1Cytokine Release Syndrome
01/2017
1Thrombosis (Thrombus)
12/2016
1Cholestasis
12/2016
1Pancytopenia
12/2016
1Radiation Injuries (Radiation Sickness)
08/2016
1Insulin Resistance
04/2016
1Obesity
04/2016
1Reinjuries
02/2016
1Lung Injury
02/2016

Drug/Important Bio-Agent (IBA)

15Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2016 - 03/2002
8LigandsIBA
12/2016 - 10/2006
7Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2009 - 04/2002
6Proteins (Proteins, Gene)FDA Link
11/2019 - 04/2002
5Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
02/2016 - 04/2005
4CytokinesIBA
11/2019 - 03/2002
4Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
05/2017 - 04/2005
3Biomarkers (Surrogate Marker)IBA
10/2017 - 01/2007
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017 - 10/2004
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2014 - 03/2002
3Oxygen (Dioxygen)IBA
01/2014 - 07/2010
3Biological ProductsIBA
11/2012 - 03/2003
3ChemokinesIBA
05/2011 - 07/2007
3Matrix Metalloproteinases (MMPs)IBA
05/2007 - 03/2003
3Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
04/2005 - 03/2002
2Phosphotransferases (Kinase)IBA
01/2022 - 01/2011
2Imatinib Mesylate (Gleevec)FDA Link
01/2020 - 06/2011
2tumor-derived adhesion factorIBA
01/2017 - 07/2009
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
12/2016 - 11/2012
2CateninsIBA
02/2016 - 02/2016
2cadherin 5IBA
02/2016 - 11/2005
2beta CateninIBA
02/2016 - 11/2005
2Small Interfering RNA (siRNA)IBA
02/2016 - 03/2007
2Metalloproteases (Metalloproteinases)IBA
01/2016 - 03/2003
2RNA (Ribonucleic Acid)IBA
02/2015 - 01/2015
2Bevacizumab (Avastin)FDA Link
12/2014 - 06/2008
2erucylphosphocholineIBA
01/2013 - 11/2008
2AlginatesIBA
05/2011 - 01/2010
2HydrogelsIBA
05/2011 - 01/2010
2Monoclonal AntibodiesIBA
06/2008 - 10/2006
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2007 - 05/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2007 - 01/2004
2Fibronectins (Fibronectin)IBA
12/2006 - 12/2005
2Stem Cell FactorIBA
05/2006 - 10/2003
2matrigelIBA
03/2005 - 03/2004
1Angiopoietin-2IBA
01/2022
1Proto-Oncogene Proteins c-etsIBA
11/2021
1Pancreatic Elastase (Elastase)IBA
01/2021
1Leucine (L-Leucine)FDA Link
01/2021
1Retinaldehyde (Retinal)IBA
01/2020
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2017
1Phosphates (Orthophosphate)IBA
10/2017
1Ethanol (Ethyl Alcohol)IBA
10/2017
1Keratins (Keratin)IBA
10/2017
1Iodized OilIBA
10/2017
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2017
1Insulin (Novolin)FDA Link
01/2017
1FibrinolysinFDA Link
01/2017
1SEW2871IBA
12/2016
1Vascular Endothelial Growth Factor BIBA
04/2016
1Chemokine ReceptorsIBA
02/2016
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2016
1Hydrochloric Acid (Hydrogen Chloride)FDA Link
02/2016

Therapy/Procedure

24Therapeutics
01/2022 - 05/2002
5Transplantation
12/2019 - 07/2003
5Drug Therapy (Chemotherapy)
10/2019 - 03/2002
2Radiotherapy
11/2020 - 05/2003
2Cell- and Tissue-Based Therapy (Cell Therapy)
10/2017 - 10/2003
2Hepatectomy
12/2016 - 11/2010
1Catheters
10/2017